NCT02719002View on ClinicalTrials.gov

Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials

NACompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

February 18, 2021

Study Completion Date

May 15, 2021

Conditions

Toxicity, DrugMaculopathy

Interventions

DEVICE

spectral domain optical coherence tomography C-scan and multifocal electroretinogram

Trial Locations (1)

75019

Fondation Ophtalmique Adolphe de Rothschild, Paris

All Listed Sponsors

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT02719002 - Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials | Biotech Hunter | Biotech Hunter